KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Total Liabilities (2016 - 2025)

Historic Total Liabilities for Abbott Laboratories (ABT) over the last 17 years, with Q3 2025 value amounting to $32.9 billion.

  • Abbott Laboratories' Total Liabilities fell 411.03% to $32.9 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $32.9 billion, marking a year-over-year decrease of 411.03%. This contributed to the annual value of $33.5 billion for FY2024, which is 254.17% down from last year.
  • Abbott Laboratories' Total Liabilities amounted to $32.9 billion in Q3 2025, which was down 411.03% from $33.2 billion recorded in Q2 2025.
  • Over the past 5 years, Abbott Laboratories' Total Liabilities peaked at $39.2 billion during Q2 2021, and registered a low of -$12.9 billion during Q4 2022.
  • For the 5-year period, Abbott Laboratories' Total Liabilities averaged around $30.6 billion, with its median value being $34.4 billion (2023).
  • Per our database at Business Quant, Abbott Laboratories' Total Liabilities plummeted by 5518.59% in 2021 and then surged by 36615.33% in 2023.
  • Quarter analysis of 5 years shows Abbott Laboratories' Total Liabilities stood at -$10.4 billion in 2021, then fell by 24.78% to -$12.9 billion in 2022, then surged by 366.15% to $34.4 billion in 2023, then dropped by 2.54% to $33.5 billion in 2024, then dropped by 1.78% to $32.9 billion in 2025.
  • Its Total Liabilities was $32.9 billion in Q3 2025, compared to $33.2 billion in Q2 2025 and $32.4 billion in Q1 2025.